CalciMedica Files to Sell Up to $25M in Stock via At-The-Market Offering

CalciMedica has filed a prospectus supplement related to the potential sale of its common stock, with an aggregate offering price of up to $25 million, through its existing at-the-market (ATM) offering agreement.

Key Details

• Offering Size: Up to $25,000,000 of common stock may be offered and sold from time to time.
• Offering Type: At-the-market (ATM) offering program.
• Sales Agent: H.C. Wainwright & Co. is the sales agent under the agreement dated August 11, 2023.
• Registration: The prospectus supplement was filed under the company's shelf registration statement on Form S-3, which became effective on March 11, 2026.